Search results
Reliance Jio announces new 5G booster plans starting at Rs 51: Check details
Indian Express· 5 days agoListed under the True Unlimited Upgrade section on the Jio website, these plans are priced at Rs 51,...
Hardik Pandya Likely To Lead India In T20I Series Against Sri Lanka Likely To Lead India In T20I...
Latest India News· 9 hours agoHardik Pandya is likely to lead the Men in Blue in the shortest format of the game. Meanwhile,...
Buy or sell: Vaishali Parekh recommends three stocks to buy today — July 4 | Stock Market News
Livemint· 7 days agoBuy or sell stocks for today: Following strong global market sentiments on the US Fed rate cut buzz,...
Ducati Hypermotard 698 Mono Launched In India, Price Starts at Rs 16.50 Lakh - News18
News18· 12 hours agoThe Italian bike maker Ducati has another model to its Hypermotard range in India. The brand has...
Linde India Ltd Management Discussions | India Infoline
India Infoline· 14 hours ago#Pertains to dividend for the financial year 2021 @ 135% including special dividend (Previous year @ 30% for the financial year 2020) on 85,284,223 equity shares of Rs.10/- each. Your Company ...
Reliance Jio silently launches affordable “True Unlimited Upgrade” prepaid plans for 5G access...
Financial Express· 5 days agoReliance Jio has silently introduced three new “true unlimited upgrade” prepaid plans, offering...
Average Of 23, No Hundreds, 4 Ducks: How Babar Azam Fared Post 'This Too Shall Pass' Tweet For Virat...
Times Now· 3 days agoFor a batter who did not score a hundred for three years, Virat went on to smash 10 centuries in the...
Mukesh Ambani's Reliance Jio introduces new plans starting at Rs 51 with unlimited 5G data for...
DNA India· 1 day agoMajor telecom companies, including Mukesh Ambani's Reliance Jio, have increased tariffs on all...
Colgate-Palmolive shares up 0.26% as Sensex rises
The Economic Times· 7 days agoEarlier in the day, the stock witnessed a gap up start to the session. The stock quoted a 52-week high price of Rs 3068.95 and a 52-week low of Rs...
iTeos and GSK hit enrolment milestone with Phase III TIGIT lung cancer trial
Pharmaceutical Technology· 1 day agoAccording to a report on GlobalData’s Pharma Intelligence Center, the number of diagnosed NSCLC...